A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Conditions
Neonatal Seizure · Neonatal Encephalopathy · Hypoxic-Ischemic Encephalopathy · Seizure Newborn
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Diego, San Diego, California, United States
University of Minnesota, Minneapolis, Minnesota, United States
Auckland City Hospital, Auckland, Auckland, New Zealand
Middlemore Hospital, Auckland, Auckland, New Zealand
Capital and Coast District Health Board, Te Whatu Ora, Health New Zealand, Wellington, Wellington Region, New Zealand
Contact: Study coordinator (Krishna Raghu, MBBS, DCH, FRACP) · krishna.raghu@ccdhb.org.nz · +64 22 309 8900Cynthia Sharpe, MBChB (Sub-investigator)
Study leads
Sonya G Wang, M.D.
Principal Investigator
University of Minnesota
Cynthia M Sharpe, M.D.
Principal Investigator
Auckland City Hospital
Jeff J Gold, M.D. PhD
Principal Investigator
University of California, San Diego
Richard H Haas, MBBChir
Principal Investigator
University of California, San Diego